Researchers identify key players in abnormal bone differentiation

FHS
June 27, 2024
5:55 am

A study conducted by researchers at Baylor College of Medicine and collaborating institutions reveals the molecular events leading to osteogenesis imperfecta type V, a form of brittle bone disease caused by a mutation in the gene IFITM5.

BIOSECURE bill targets more Chinese companies as biotechs and their customers adapt to defunding – Pharmaceutical Technology

Share this article US lawmakers have selected additional Chinese biotechnology companies as potentially Chinese military-backed companies. Credit: WD Stuart via Getty Images US lawmakers have

April 29, 2024

CMS begins national coverage review for tricuspid repair

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The Centers for Medicare and

October 8, 2024

Q&A: FDA’s Peter Marks ready to encourage more accelerated approvals for rare diseases

FDA biologics center director Peter Marks said the agency plans to encourage sponsors to use the accelerated approval pathway, particularly for rare disease treatments, as

August 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.